Mumbai, Nov. 7 -- Revenue from operations rose 31.71% to Rs 960.74 crore in Q2 FY26, compared with Rs 1,406.91 crore in Q2 FY25. Profit before tax exceptional item and tax declined 58.70% to Rs 42.30... Read More
Sri Lanka, Nov. 7 -- The Sri Lanka Tourism Development Authority (SLTDA) has announced that the total number of foreign tourists who have visited the country so far in 2025 has exceeded 1.9 million. ... Read More
Mumbai, Nov. 7 -- The Australian dollar extends decline near a three week low against the dollar tracing strength in dollar overseas. The greenback gained ground amid reduced expectations of a Decembe... Read More
Dehradun, Nov. 7 -- Garhwal Post Bureau Mussoorie, 5 Nov: At a programme organised to mark the Silver Jubilee of the formation of Uttarakhand, protestors and speakers remembered the martyrs' sacrific... Read More
India, Nov. 7 -- Maharani season 4 ending, explained: If Indian political dramas have taught us anything, it's that road to power is essentially a family WhatsApp group gone wrong. The fourth season o... Read More
Belem, Brazil, Nov. 7 -- Indonesia reaffirmed its commitment to strengthening national climate action during the Belem Leader Summit in Brazil, according to President Prabowo Subianto's Special Envoy ... Read More
France, Nov. 7 -- Tunisia's migration policy is under scrutiny two years on from a deal with the European Union intended to discourage illegal migration from the North African country, and from a "rep... Read More
India, Nov. 7 -- If you have been waking up to endless headlines about Lily Allen, her relationships and other controversial details from her dating history these past few days, you're definitely not ... Read More
Mumbai, Nov. 7 -- The stock was listed at Rs 570, reflecting a discount of 2.56% to the issue price. So far, the stock has hit a high of 585 and a low of 555.80. On the BSE, over 4.13 lakh shares of ... Read More
U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225439) titled 'Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relap... Read More